葡萄糖轉運蛋白1(GLUT1)重組蛋白
Recombinant Glucose Transporter 1 (GLUT1)
SLC2A1; SLC2-A1; GLUT; Solute Carrier Family 2 Member 1,Facilitated Glucose Transporter; Glucose transporter type 1, erythrocyte/brain; HepG2 glucose transporter
- 編號RPB185Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞膜
- 預測分子量22.4kDa
- 實際分子量27kDa(差異分析請參閱說明書)
- 片段與標簽Met251~Glu329 with Two N-terminal Tags, His-tag and SUMO-tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點9.6
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1944 ¥ 4860 ¥ 9720 ¥ 29160 ¥ 72900
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Figure . Gene Sequencing (extract)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB185Mu01 | 葡萄糖轉運蛋白1(GLUT1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
參考文獻
| 雜志 | 參考文獻 |
| Biosensors | Single Step Nanoplasmonic Immunoassay for the Measurement of Protein Biomarkers [Mdpi: Source] |
| Neurotoxicity Research | N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression [Pubmed:26861954] |
| Scientific Reports | Oral formulation of DPP-4 inhibitor plus Quercetin improves metabolic homeostasis in type 1 diabetic rats [Pubmed: 30333575] |
| Neurotoxicity Research | Brain Metabolic Alterations in Rats Showing Depression-Like and Obesity Phenotypes [Pubmed: 31782099] |
| Comparative study about ageing effect on retina and cerebellum of Columba livia domestica [] | |
| Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC) [] | |
| J Cell Mol Med | Huaier shows anti?\cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K/AKT/HIF?\1|á pathway [33377619] |
留言咨詢
